TRACON Pharmaceuticals Inc (TCON)
0.8499
-0.15
(-15.01%)
USD |
OTCM |
Jul 03, 16:00
TRACON Pharmaceuticals Revenue (Annual): 12.04M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.04M |
| December 31, 2022 | |
| December 31, 2021 | 0.346M |
| December 31, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | 3.00M |
| December 31, 2017 | 8.755M |
| December 31, 2016 | 3.449M |
| December 31, 2015 | 7.904M |
| December 31, 2014 | 3.598M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.346M
Minimum
2021
12.04M
Maximum
2023
6.196M
Average
6.196M
Median
Revenue (Annual) Benchmarks
| BioSig Technologies Inc | 0.018M |
| Revolution Medicines Inc | 11.58M |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 48.07M |
| Xtant Medical Holdings Inc | 91.30M |